GeneticTesting
Anne Wojcicki is taking back control of 23andMe
Anne Wojcicki is taking back control of 23andMe Anne Wojcicki is buying back 23andMe after it filed for Chapter 11 bankruptcy protection earlier this year. The new purchase agreement is worth $305 million, following a final round of bidding between TTAM and Regeneron Pharmaceuticals. Regeneron was initially set to buy 23andMe for $256 million, but […]
💻 Technology